Department of Integrative Oncology, Brio Medical Center, Arizona, USA
Case Report
Histologic and Radiographic SSTR2 Overexpression in a Cancer Patient with Clinical and Pathologic Features Initially Treated as a Breast Cancer Protocol: A Case Report
Author(s): Kim Walter, Beaty Debbie*, Goodyear Nathan, Labant Miranda, Rawls Tequilea and Spat Tam
Neuroendocrine Neoplasms (NENs) or Neuroendocrine Tumors (NETs) are an extremely rare malignancy only comprising about two percent of all malignancies, making them difficult to diagnose and treat. Neuroendocrine tumors are those that arise from specialized neuroendocrine cells originating in many organs and causing a wide range of symptoms that could easily be mistaken with other conditions. These NEN’s are then divided into two subgroups: well-differentiated (low to intermediate grade) also called carcinoid tumors missing the characteristic neuroendocrine nuclei, and poorly differentiated (high grade) neuroendocrine carcinomas. Although there is not consensus as to the diagnostic criteria for neuroendocrine differentiation, it most often requires the expression of chromogranin-A, synaptophysin or neuron-specific enolase, in at least 50% of malignant tumor cells. Neuroendocrine .. Read More»
DOI:
10.37421/2329-6771.2022.12.424
Journal of Integrative Oncology received 495 citations as per Google Scholar report